Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
British Journal of Pharmacology|October 23, 2009
Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptorsClark A Briggs, Jens Halvard Grønlien, Peter Curzon, et al.
EMBO Molecular Medicine|February 24, 2016
Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotidesAnthony J Hinrich, Francine M Jodelka, Jennifer L Chang, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2007
An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivoDaniel B Timmermann, Jens Halvard Grønlien, Kathy L Kohlhaas, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 20, 2021
GluN3-Containing NMDA Receptors in the Rat Nucleus Accumbens Core Contribute to Incubation of Cocaine CravingDaniel T Christian, Michael T Stefanik, Linda A Bean, et al.
Journal of Medicinal Chemistry|May 8, 2009
Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptorRamin Faghih, Sujatha M Gopalakrishnan, Jens Halvard Gronlien, et al.
Acta Neuropathologica|June 21, 2017
Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficitsAlain Lacampagne, Xiaoping Liu, Steven Reiken, et al.
CNS Drug Reviews|June 5, 2004
ABT-089: pharmacological properties of a neuronal nicotinic acetylcholine receptor agonist for the potential treatment of cognitive disordersLynne E Rueter, David J Anderson, Clark A Briggs, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 28, 2007
Broad-spectrum efficacy across cognitive domains by alpha7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathwaysRobert S Bitner, William H Bunnelle, David J Anderson, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 28, 2010
In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107John Malysz, David J Anderson, Jens H Grønlien, et al.
CNS Neuroscience & Therapeutics|May 17, 2008
Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing propertiesKarin R Tietje, David J Anderson, R Scott Bitner, et al.
Pageof 3